- Home
- VFC vs ICUI Comparison
VFC vs ICUI Comparison
Compare VFC & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VFC
- ICUI
- Stock Information
- Founded
- VFC 1899
- ICUI 1984
- Country
- VFC United States
- ICUI United States
- Employees
- VFC N/A
- ICUI N/A
- Industry
- VFC Apparel
- ICUI Medical/Dental Instruments
- Sector
- VFC Consumer Discretionary
- ICUI Health Care
- Exchange
- VFC Nasdaq
- ICUI Nasdaq
- Market Cap
- VFC 4.1B
- ICUI 3.4B
- IPO Year
- VFC N/A
- ICUI 1992
- Fundamental
- Price
- VFC $12.48
- ICUI $135.44
- Analyst Decision
- VFC Buy
- ICUI Strong Buy
- Analyst Count
- VFC 18
- ICUI 5
- Target Price
- VFC $16.28
- ICUI $196.75
- AVG Volume (30 Days)
- VFC 7.1M
- ICUI 219.2K
- Earning Date
- VFC 08-05-2025
- ICUI 08-06-2025
- Dividend Yield
- VFC 2.86%
- ICUI N/A
- EPS Growth
- VFC N/A
- ICUI N/A
- EPS
- VFC N/A
- ICUI N/A
- Revenue
- VFC $9,504,691,000.00
- ICUI $2,420,093,000.00
- Revenue This Year
- VFC $0.92
- ICUI N/A
- Revenue Next Year
- VFC $3.39
- ICUI N/A
- P/E Ratio
- VFC $70.62
- ICUI N/A
- Revenue Growth
- VFC N/A
- ICUI 7.22
- 52 Week Low
- VFC $9.41
- ICUI $116.46
- 52 Week High
- VFC $29.02
- ICUI $196.26
- Technical
- Relative Strength Index (RSI)
- VFC 53.47
- ICUI 55.28
- Support Level
- VFC $11.42
- ICUI $128.50
- Resistance Level
- VFC $12.82
- ICUI $137.10
- Average True Range (ATR)
- VFC 0.48
- ICUI 3.86
- MACD
- VFC 0.11
- ICUI 0.79
- Stochastic Oscillator
- VFC 86.36
- ICUI 81.35
About VFC V.F. Corporation
VF designs, produces, and distributes branded apparel, footwear, and accessories. Its apparel categories are active, outdoor, and work. Its portfolio of 11 brands includes Vans, The North Face, Timberland, Altra, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. Tracing its roots to 1899, the company has evolved through many brand acquisitions and dispositions.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.